(Q38299914)

1 September 2017

title

Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome (English)

1 reference

1 September 2017

G Grugni

1

1 reference

1 September 2017

G Guzzaloni

series ordinal

2

1 reference

1 September 2017

F Morabito

series ordinal

3

1 reference

1 September 2017

publication date

1 May 2001

1 reference

Journal of Endocrinological Investigation

1 September 2017

published in

1 reference

1 September 2017

volume

24

1 reference

1 September 2017

issue

5

1 reference

1 September 2017

page(s)

340-348

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03343871

1 September 2017

exact match

0 references

cites work

On the actions of the growth hormone-releasing hexapeptide, GHRP.

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

A receptor in pituitary and hypothalamus that functions in growth hormone release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

Growth hormone-releasing peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

Disturbances in the growth hormone-insulin-like growth factor axis in children and adolescents with different eating disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

The Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

Variations in pattern of pubertal changes in girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

Variations in the Pattern of Pubertal Changes in Boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

The effect of simple obesity on growth and growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

Reference values for height and weight in Prader-Willi syndrome based on 315 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

MR of the pituitary in patients with Prader-Willi syndrome: size determination and imaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

Role of the new growth hormone-releasing secretagogues in the diagnosis of some hypothalamopituitary pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

Long term pulsatile growth hormone (GH)-releasing hormone therapy in children with GH deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

The effects of a growth hormone-releasing Peptide and growth hormone-releasing factor in conscious and anaesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343871

Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhard-Willi syndrome

21 January 2018

1 reference

12 December 2020

Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep

1 reference

12 December 2020

Growth hormone releasing hexapeptide-6 (GHRP-6) test in the diagnosis of GH-deficiency

1 reference

12 December 2020

Prader-Willi syndrome and the hypothalamus

1 reference

12 December 2020

Prader-Willi syndrome: consensus diagnostic criteria.

1 reference

12 December 2020

On a peptidomimetic growth hormone-releasing peptide

1 reference

12 December 2020

Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome

1 reference

12 December 2020

Somatotropic function in short stature: evaluation by integrated auxological and hormonal indices in 214 children. The Italian Collaborative Group of Neuroendocrinology

1 reference

12 December 2020

1 reference

12 December 2020

Growth hormone-releasing peptide and its analogues Novel stimuli to growth hormone release

1 reference

12 December 2020

The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa

1 reference

12 December 2020

The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects

1 reference

12 December 2020

Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6

1 reference

12 December 2020

Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group

1 reference

12 December 2020

Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection

1 reference

12 December 2020

Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors

1 reference

12 December 2020

Secretion of growth hormone releasing hormone in obese children

1 reference

12 December 2020

The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency

1 reference

12 December 2020

Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hyp

1 reference

12 December 2020

Growth hormone (GH) responses to GH-releasing peptide and to GH-releasing hormone in GH-deficient children

1 reference

12 December 2020

Growth hormone neurosecretory dysfunction. A treatable cause of short stature

1 reference

12 December 2020

Growth hormone secretion in Prader-Willi syndrome

1 reference

12 December 2020

Adiposity indices in children

1 reference

12 December 2020

Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6

1 reference

12 December 2020

Hypothalamic targets for growth hormone secretagogues.

1 reference

12 December 2020

Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency

1 reference

12 December 2020

Growth hormone in obesity

1 reference

12 December 2020

Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03343871

1 reference

1 September 2017

1 reference